Philippines Pharma Industry Forecasts Slower Growth This Year
This article was originally published in PharmAsia News
The Philippines' pharmaceutical industry expects the economic situation in the country to lead to slower sales growth this year at a time when the patents of some local companies also expire. The Pharmaceutical and Healthcare Association of the Philippines projects sales growth at no more than 6 percent, down from 10.2 percent last year. The expected 5-6 percent growth rate is expected to be supported in part by increased research and development by the industry. PHAP Executive Director Reiner Gloor said R&D is of greater importance as the local industry meets global competition. (Click here for more
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.